Use of novel antiretroviral agents in rescue regimens: A case of early virological failure to raltegravir

Chiara Tommasi, Francesca Ceccherini-Silberstein, Roberta D'Arrigo, Rita Bellagamba, Massimo Tempestilli, Carlo Dess, Maria M. Santoro, Federica Forbici, Emanuele Nicastri, Leopoldo P. Pucillo, Carlo F. Perno, Pasquale Narciso

Research output: Contribution to journalArticle


In patients with virological failure during highly active antiretroviral therapy (HAART) and drug resistance, guidelines recommend the achievement of maximal virological suppression by the use of a new regimen with at least 2 active drugs. We describe the clinical outcome of a heavily antiretroviral- experienced patient who experienced early failure to raltegravir.

Original languageEnglish
Pages (from-to)237-239
Number of pages3
JournalScandinavian Journal of Infectious Diseases
Issue number3
Publication statusPublished - 2010


ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Microbiology(all)
  • Infectious Diseases

Cite this